Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,434 | -9,337 | -38,946 | -30,426 | -17,683 |
| Depreciation Amortization | 2,659 | 1,330 | 7,934 | 6,675 | 2,486 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -5 |
| Accounts receivable | 1 | 1 | 107 | 70 | 67 |
| Accounts payable and accrued liabilities | 334 | 426 | 134 | 42 | 114 |
| Other Working Capital | -2,228 | -1,053 | 1,128 | 526 | -965 |
| Other Operating Activity | 1,872 | 698 | 4,529 | 3,754 | 2,329 |
| Operating Cash Flow | $-18,797 | $-7,936 | $-25,113 | $-19,359 | $-13,656 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 176 | -10,000 | -10,000 |
| PPE Investments | -7,469 | -3,545 | -6,590 | -4,438 | -2,168 |
| Purchase Sale Intangibles | -752 | -619 | -197 | -34 | -34 |
| Other Investing Activity | -752 | -619 | -195 | -33 | -34 |
| Investing Cash Flow | $-8,221 | $-4,164 | $-6,609 | $-14,471 | $-12,202 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 14,546 | 6,132 | N/A | 0 | 0 |
| Common Stock Issued | 17,317 | 16,148 | 73,090 | 73,092 | 31,672 |
| Common Stock Repurchased | -1,039 | -1,039 | -9,976 | -2,536 | -2,536 |
| Financing Cash Flow | $30,824 | $21,241 | $63,114 | $70,556 | $29,136 |
| Exchange Rate Effect | 95 | 84 | -148 | -368 | -61 |
| Beginning Cash Position | 52,813 | 52,813 | 21,568 | 21,568 | 21,568 |
| End Cash Position | 56,714 | 62,038 | 52,813 | 57,925 | 24,786 |
| Net Cash Flow | $3,901 | $9,225 | $31,245 | $36,357 | $3,217 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,797 | -7,936 | -25,113 | -19,359 | -13,656 |
| Capital Expenditure | -7,469 | -3,545 | -6,590 | -4,438 | -2,168 |
| Free Cash Flow | -26,266 | -11,481 | -31,703 | -23,797 | -15,823 |